Valeant Pharma (VRX) CEO Joe Papa total compensation was $62.7 million in 2016
Valeant Pharma (NYSE: VRX) CEO Joe Papa total compensation was $62.7 million in 2016.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Splash Beverage Group Inc. (SBEV) Appoints Julius Ivancsits as CFO
- Nanometrics (NANO) Issues Business Update, Reports FY23 Results
Create E-mail Alert Related Categories
Corporate News, Management Changes, Management Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!